Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery
It is well known that the pH of tumor tissue is lower than that of the corresponding normal adjacent tissue. Here, the authors report a clinical trial of a pH activatable nanoparticle for imaging tumours.
Guardado en:
Autores principales: | F. J. Voskuil, P. J. Steinkamp, T. Zhao, B. van der Vegt, M. Koller, J. J. Doff, Y. Jayalakshmi, J. P. Hartung, J. Gao, B. D. Sumer, M. J. H. Witjes, G. M. van Dam, the SHINE study group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f464a72146f5457993946c6a765cc8dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy
por: Xu Zhao, et al.
Publicado: (2017) -
A H2O2-activatable nanoprobe for diagnosing interstitial cystitis and liver ischemia-reperfusion injury via multispectral optoacoustic tomography and NIR-II fluorescent imaging
por: Junjie Chen, et al.
Publicado: (2021) -
Haptoglobin and serum amyloid a in subacute ruminal acidosis in goats
por: F.H.D. González, et al.
Publicado: (2010) -
PANDAA intentionally violates conventional qPCR design to enable durable, mismatch-agnostic detection of highly polymorphic pathogens
por: Iain J. MacLeod, et al.
Publicado: (2021) -
Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
por: Luiza N. Weis, et al.
Publicado: (2021)